Auxly Cannabis Group Inc. Stock: price and insider trades · Canada

Auxly Cannabis Group Inc. is a Health Care company. Its directors and officers file their transactions with SEDI. The last twelve months, up to 18 October 2026, brought 92 filings signed by 8 insiders.

The flow runs one way only: 2 insiders bought (4 purchases totalling €80k) and nobody sold on the market. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 2 senior executives among the declarants. One trade stands out by size: a purchase of €49k from Alves, Hugo M., disclosed on 19 June 2026, or 0.026% of market capitalisation.

Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 92 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 4 purchases and no sales.

The latest purchase dates back some time: it was published 51 days ago, on 27 August 2026. Typically, a trade is published a median of 16 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.